End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.49 CNY | +1.03% | +9.96% | +23.07% |
19/04 | Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
18/04 | Haisco Pharmaceutical Gets Nod to Trial HSK16149 Capsules | MT |
Sales 2024 * | 3.88B 535M 44.6B | Sales 2025 * | 5.1B 704M 58.73B | Capitalization | 31.44B 4.34B 362B |
---|---|---|---|---|---|
Net income 2024 * | 552M 76.18M 6.35B | Net income 2025 * | 633M 87.36M 7.28B | EV / Sales 2024 * | 8.11 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 6.16 x |
P/E ratio 2024 * |
57
x | P/E ratio 2025 * |
50.4
x | Employees | 5,448 |
Yield 2024 * |
0.42% | Yield 2025 * |
0.53% | Free-Float | 20.41% |
1 day | +1.03% | ||
1 week | +9.96% | ||
Current month | +5.01% | ||
1 month | +8.20% | ||
3 months | +25.56% | ||
6 months | +19.45% | ||
Current year | +23.07% |
Managers | Title | Age | Since |
---|---|---|---|
Xiu Lian Fan
CEO | Chief Executive Officer | 61 | 01/07/01 |
Peng Duan
DFI | Director of Finance/CFO | 49 | 21/16/21 |
Jun Min Wang
CHM | Chairman | 56 | 01/07/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jun Min Wang
CHM | Chairman | 56 | 01/07/01 |
Wei Zheng
BRD | Director/Board Member | 54 | 01/07/01 |
Xiu Lian Fan
CEO | Chief Executive Officer | 61 | 01/07/01 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 28.49 | +1.03% | 5,014,870 |
25/24/25 | 28.2 | +3.37% | 5,018,471 |
24/24/24 | 27.28 | +1.41% | 3,321,500 |
23/24/23 | 26.9 | +1.89% | 4,695,500 |
22/24/22 | 26.4 | +1.89% | 5,111,822 |
End-of-day quote Shenzhen S.E., April 26, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.07% | 4.34B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 002653 Stock